Maximilian M. L. Knott
Tel Aviv University(IL)German Cancer Research Center(DE)Heidelberg University(DE)University Hospital Heidelberg(DE)LMU Klinikum(DE)National Center for Tumor Diseases(DE)Hopp Children's Cancer Center Heidelberg(DE)Ludwig-Maximilians-Universität München(DE)
Publications by Year
Research Areas
Chemokine receptors and signaling, Sarcoma Diagnosis and Treatment, Inflammatory mediators and NSAID effects, Immunotherapy and Immune Responses, Immune Cell Function and Interaction
Most-Cited Works
- → CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes(2019)260 cited
- → Novel antigen-presenting cell imparts Treg-dependent tolerance to gut microbiota(2022)240 cited
- → PHGDH heterogeneity potentiates cancer cell dissemination and metastasis(2022)206 cited
- → Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells(2016)99 cited
- → Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets(2017)91 cited
- → Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression(2015)77 cited